Sildenafil and Nitroglycerin Interaction

Drug interaction information between Sildenafil and Nitroglycerin.

Sildenafil and Nitroglycerin have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Sildenafil and Nitroglycerin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Sildenafil

PDE5 Inhibitor

Drug B

Nitroglycerin

Nitrate Vasodilator

How They Interact

Both of these drugs work to relax and widen your blood vessels. Taking them together can cause your blood pressure to drop to a dangerously low level.

FDA Label Information

PDE-5-Inhibitors such as avanafil, sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates.

Frequently Asked Questions

What SPL severity band is on file for Sildenafil + Nitroglycerin?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Sildenafil has 10 labeled pairs on file vs Nitroglycerin's 8. In the minor band specifically: Sildenafil has 3 (also Amlodipine, Amlodipine/Valsartan); Nitroglycerin has 6 (also Aspirin, Tadalafil, Heparin, Isradipine).

What mechanism field is on file for Sildenafil and Nitroglycerin?

Both of these drugs work to relax and widen your blood vessels. Taking them together can cause your blood pressure to drop to a dangerously low level.

Sildenafil carries more major-labeled pairs than Nitroglycerin

SPL source-record counts only. This page's band is minor · classes on file: Sildenafil (PDE5 Inhibitor); Nitroglycerin (Nitrate Vasodilator).

Sildenafil has 6 major-labeled pairs vs Nitroglycerin's 0. This page itself is in the minor band, not the major band.

Sildenafil

6 major · 1 moderate · 3 minor · 10 total

Nitroglycerin

0 major · 2 moderate · 6 minor · 8 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.